1. Home
  2. HSCS vs RDHL Comparison

HSCS vs RDHL Comparison

Compare HSCS & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSCS
  • RDHL
  • Stock Information
  • Founded
  • HSCS 2007
  • RDHL 2009
  • Country
  • HSCS United States
  • RDHL Israel
  • Employees
  • HSCS N/A
  • RDHL N/A
  • Industry
  • HSCS Medical Specialities
  • RDHL Biotechnology: Pharmaceutical Preparations
  • Sector
  • HSCS Health Care
  • RDHL Health Care
  • Exchange
  • HSCS Nasdaq
  • RDHL Nasdaq
  • Market Cap
  • HSCS 3.7M
  • RDHL 4.3M
  • IPO Year
  • HSCS 2022
  • RDHL N/A
  • Fundamental
  • Price
  • HSCS $3.94
  • RDHL $1.71
  • Analyst Decision
  • HSCS Strong Buy
  • RDHL
  • Analyst Count
  • HSCS 2
  • RDHL 0
  • Target Price
  • HSCS $13.00
  • RDHL N/A
  • AVG Volume (30 Days)
  • HSCS 187.6K
  • RDHL 1.4M
  • Earning Date
  • HSCS 07-24-2025
  • RDHL 08-28-2025
  • Dividend Yield
  • HSCS N/A
  • RDHL N/A
  • EPS Growth
  • HSCS N/A
  • RDHL N/A
  • EPS
  • HSCS N/A
  • RDHL N/A
  • Revenue
  • HSCS $4,350.00
  • RDHL $8,042,999.00
  • Revenue This Year
  • HSCS $21,003.45
  • RDHL $381.91
  • Revenue Next Year
  • HSCS $533.33
  • RDHL N/A
  • P/E Ratio
  • HSCS N/A
  • RDHL N/A
  • Revenue Growth
  • HSCS N/A
  • RDHL 23.17
  • 52 Week Low
  • HSCS $2.36
  • RDHL $1.71
  • 52 Week High
  • HSCS $6.47
  • RDHL $20.28
  • Technical
  • Relative Strength Index (RSI)
  • HSCS 49.70
  • RDHL 42.41
  • Support Level
  • HSCS $3.62
  • RDHL $1.86
  • Resistance Level
  • HSCS $4.14
  • RDHL $3.31
  • Average True Range (ATR)
  • HSCS 0.67
  • RDHL 0.29
  • MACD
  • HSCS -0.05
  • RDHL -0.04
  • Stochastic Oscillator
  • HSCS 12.15
  • RDHL 0.00

About HSCS Heart Test Laboratories Inc.

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

Share on Social Networks: